Findings

What do systematic reviews say?

45 questions · 48 findings · 2 reviews · Common Mental Disorders

No studies found 14 · 29.2%GRADE not reported 0 · 0%Very low 21 · 43.8%Low 10 · 20.8%Moderate 3 · 6.3%High 0 · 0%

Efficacy: number of participants who respond to treatment ‐ not reported · adults (aged 18 years+) with depression in bipolar disorder

The review found no eligible studies for this question.

1 finding from 1 review

Ketamine and other glutamate receptor modulators for depression in adults with bipolar disorder 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Remission · adults (aged 18 years+) with depression in bipolar disorder

The review found no eligible studies for this question.

1 finding from 1 review

Ketamine and other glutamate receptor modulators for depression in adults with bipolar disorder 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Depression rating scale scores ‐ not reported · adults (aged 18 years+) with depression in bipolar disorder

The review found no eligible studies for this question.

1 finding from 1 review

Ketamine and other glutamate receptor modulators for depression in adults with bipolar disorder 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Acceptability ‐ total dropouts · adults (aged 18 years+) with depression in bipolar disorder

It is very uncertain whether riluzole changes acceptability: total dropouts compared with placebo (very low certainty).

1 finding from 1 review

Withdrawals due to adverse events · adults (aged 18 years+) with depression in bipolar disorder

The review found no eligible studies for this question.

1 finding from 1 review

Ketamine and other glutamate receptor modulators for depression in adults with bipolar disorder 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found